IMPORTANT REMINDER: New DEA Education Requirement on Opioid or other Substance Use Disorders Begins June 27

June 8, 2023

Beginning June 27, DEA license holders, upon initial registration or renewal, will be required to complete at least eight hours of training in the treatment or management of patients with opioid or other substance use disorders. 

To ensure you have the most accurate information, you should review the guidance issued by the DEA. Click here to find the MMA’s recommendations for members who need to complete this training. 

Latest News

National Medical Specialty Societies Offer Vaccine Guidance

September 3, 2026

On September 2, the Vaccine Integrity Project (VIP) at the University of Minnesota’s Center for Infectious Disease Research and Policy, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, and the Infectious Diseases Society of America issued guidelines recommending Americans continue to get immunized for influenza, COVID-19, and respiratory syncytial virus (RSV).   

Sanford Health and North Memorial Health Finalize Partnership

September 3, 2026

On September 1, Sanford Health and North Memorial Health announced that they had finalized their partnership, and are now one non-profit integrated health system operating as Sanford Health.  

State Releases Fact Sheet on Preparing for Patients Using Concentrated 7-OH Products

September 3, 2026

The Minnesota Department of Health (MDH), in collaboration with the MMA and partner physicians, has released an informational brief on concentrated 7‑hydroxymitragynine (7‑OH) and other kratom products, which are increasingly available in commercial forms such as tablets, gummies, liquids, and “enhanced” or “spiked” kratom products.